8-OH-DPAT ATTENUATES THE DEXFENFLURAMINE-INDUCED INCREASE IN EXTRACELLULAR SEROTONIN - AN IN-VIVO DIALYSIS STUDY

被引:12
|
作者
GARDIER, AM
TRILLAT, AC
MALAGIE, I
JACQUOT, C
机构
[1] Faculté de Pharmacie, Laboratoire de Pharmacologie JE 92-372, F-92296 Chatenay-Malabry Cedex, Tour D1
关键词
DEXFENFLURAMINE; 8-OH-DPAT (8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN); 5-HT1A AUTORECEPTOR; 5-HT; (5-HYDROXYTRYPTAMINE; SEROTONIN); RELEASE; FRONTAL CORTEX; MICRODIALYSIS;
D O I
10.1016/0014-2999(94)90231-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Rats with frontocortical microdialysis probes were treated with dexfenfluramine or dexfenfluramine with 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) pretreatement. Dexfenfluramine (10 mg/kg i.p.) increased extracellular serotonin (5-hydroxytryptamine, 5-HT) (calculated area under the curve (AUC) for the 0 to 105-min period after dexfenfluramine treatment = 8.22 +/- 2.66 pmol 5-HT). Systemic (0.025 mg/kg i.p.) or local (0.01 mu M into the dorsal raphe nucleus) 8-OH-DPAT pretreatement decreased the dexfenfluramine response (AUC: 1.03 +/- 0.07 and 0.44 +/- 0.04 pmol 5-HT, respectively). This result might be explained by the decrease in 5-HT neuronal discharge caused by somatodendritic 5-HT1A autoreceptor activation, and suggests that the 5-HT releasing effect of dexfenfluramine in vivo depends on nerve terminal depolarization.
引用
收藏
页码:107 / 110
页数:4
相关论文
共 35 条
  • [11] FLUOXETINE ATTENUATES THE DL-FENFLURAMINE-INDUCED INCREASE IN EXTRACELLULAR SEROTONIN AS MEASURED BY INVIVO DIALYSIS
    SABOL, KE
    RICHARDS, JB
    SEIDEN, LS
    BRAIN RESEARCH, 1992, 585 (1-2) : 421 - 424
  • [12] Biochemical and molecular modeling study focused on stereoselectivity of 8-OH-DPAT toward the serotonin 5-HT1A receptor
    Dabrowska, J
    Brylinski, M
    Nowak, P
    Brus, R
    PHARMACOLOGICAL REPORTS, 2006, 58 (02) : 294 - 294
  • [13] THE BEHAVIORAL-EFFECTS OF A SEROTONIN-1A AGONIST, 8-OH-DPAT, ON HALOPERIDOL-INDUCED DYSTONIA IN NONHUMAN-PRIMATES
    CASEY, DE
    NEUROPSYCHOPHARMACOLOGY, 1993, 9 (02) : S168 - S168
  • [14] Combined therapy with 8-OH-DPAT and nimodipine against in vivo NMDA-induced cell death in rat nucleus basalis
    Stuiver, BT
    Stienstra, CM
    Oosterink, BJ
    Nyakas, C
    Luiten, PGM
    NEUROCHEMISTRY: CELLULAR, MOLECULAR, AND CLINICAL ASPECTS, 1997, : 351 - 355
  • [15] EFFECT OF LOCAL INJECTION OF 8-OH-DPAT INTO THE DORSAL OR MEDIAN RAPHE NUCLEI ON EXTRACELLULAR LEVELS OF SEROTONIN IN SEROTONERGIC PROJECTION AREAS IN THE RAT-BRAIN
    BONVENTO, G
    SCATTON, B
    CLAUSTRE, Y
    ROUQUIER, L
    NEUROSCIENCE LETTERS, 1992, 137 (01) : 101 - 104
  • [16] Combined therapy with nimodipine and 8-OH-DPAT against in vivo NMDA-induced cell death in rat nucleus basalis
    Stuiver, BT
    Stienstra, CM
    Oosterink, BJ
    Luiten, PGM
    JOURNAL OF NEUROCHEMISTRY, 1996, 66 : S22 - S22
  • [17] IN-VIVO AND IN-VITRO ALKYLATION OF [H-3] 8-OH-DPAT BINDING-SITES IN RAT CEREBRAL-CORTEX AND HIPPOCAMPUS
    READER, TA
    RADJA, F
    CARLI, M
    AFKHAMIDASTJERDIAN, S
    NENONENE, EK
    JOURNAL OF NEUROCHEMISTRY, 1995, 65 : S28 - S28
  • [18] PARA-CHLOROPHENYLALANINE PREVENTS FEEDING INDUCED BY THE SEROTONIN AGONIST "8-HYDROXY-2-(DI-NORMAL-PROPYLAMINO) TETRALIN (8-OH-DPAT)
    DOURISH, CT
    HUTSON, PH
    CURZON, G
    PSYCHOPHARMACOLOGY, 1986, 89 (04) : 467 - 471
  • [19] The 5-HT1A receptor agonist, 8-OH-DPAT, attenuates long-lasting pain in imiquimod-induced psoriasis in mice
    Cervantes-Duran, Claudia
    Avalos-Viveros, Miguel
    Torner, Luz
    Sanchez-Ceja, Sandra-Guadalupe
    Rodriguez-Orozco, Alain-Raimundo
    Martinez-Flores, Hector-Eduardo
    Garcia-Perez, Martha-Estrella
    EXPERIMENTAL DERMATOLOGY, 2022, 31 (04) : 600 - 607
  • [20] 8-OH-DPAT (5-HT1A agonist) Attenuates 6-Hydroxy-dopamine-induced catalepsy and Modulates Inflammatory Cytokines in Rats
    Sharifi, Hamdolah
    Nayebi, Alireza Mohajjel
    Farajnia, Safar
    IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2013, 16 (12) : 1270 - 1275